Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2/3
×
Recruiting
×
Lymphangioma, Cystic
×
Clear all
Filters
3
NCT05948943
2026-02-13
EPIK-L1
Novartis
Phase 2/3
Recruiting
232 enrolled